Free Trial
OTCMKTS:BTCA

Bactolac Pharmaceutical (BTCA) Stock Price, News & Analysis

→ Wall Street Legend Issues New NVDA Warning (From Chaikin Analytics) (Ad)
Free BTCA Stock Alerts
$120,000.00
0.00 (0.00%)
(As of 09/18/2017)
Compare
Today's Range
$120,000.00
▼
$120,000.00
50-Day Range
$120,000.00
▼
$120,000.00
52-Week Range
$120,000.00
▼
$120,000.00
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
BTCA stock logo

About Bactolac Pharmaceutical Stock (OTCMKTS:BTCA)

Bactolac Pharmaceutical, Inc. engages in the research, development and commercialization of vitamins and neutraceuticals. It offers nutritional supplements and shake powders, resveratrol, probiotics, multivitamins, antioxidant products, sports and hormone supplements, and weight loss and detoxification drugs. The company was founded by Pailla Malla Reddy in 1995 and is headquartered in Hauppauge, NY.

BTCA Stock Price History

BTCA Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive BTCA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bactolac Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/24/2024
Fiscal Year End
9/30/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drugs, Proprietaries, & Sundries
Sub-Industry
N/A
Current Symbol
OTCMKTS:BTCA
CUSIP
N/A
CIK
N/A
Web
www.nnfa.org
Phone
(631) 951-4908
Fax
N/A
Employees
126
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
0.01
10 Best Stocks to Own in 2024 Cover
10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Pailla Malla Reddy
    Chairman, President & Chief Executive Officer
  • Hanuman Rao Davuluri
    Director-Operations & Formulation Department
  • Renee Reynolds
    Chief Financial Officer, Co-Secretary & VP
  • Venkat Reddy Guduru
    Chief Scientific Officer
  • Gregory S. Pusey
    Director & Assistant Secretary

Key Competitors

View All Competitors

BTCA Stock Analysis - Frequently Asked Questions

How have BTCA shares performed in 2024?

Bactolac Pharmaceutical's stock was trading at $120,000.00 at the start of the year. Since then, BTCA stock has increased by 0.0% and is now trading at $120,000.00.
View the best growth stocks for 2024 here.

How do I buy shares of Bactolac Pharmaceutical?

Shares of BTCA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BTCA) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
Wall Street Legend Issues New NVDA Warning
Chaikin Analytics
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency